Teladoc Health Files Q2 2025 10-Q Report
Ticker: TDOC · Form: 10-Q · Filed: 2025-07-30T00:00:00.000Z
Sentiment: neutral
Topics: 10-Q, quarterly-report, healthcare
TL;DR
Teladoc's Q2 2025 10-Q is in. Check financials for the latest.
AI Summary
Teladoc Health, Inc. filed its quarterly report for the period ending June 30, 2025. The company's principal executive offices are located at 155 E 44th Street, Floor 17, New York, NY 10017. The filing covers the period from January 1, 2025, to June 30, 2025, and includes comparative data for the same period in 2024.
Why It Matters
This filing provides investors with an update on Teladoc Health's financial performance and operational status for the second quarter of 2025, crucial for understanding the company's trajectory.
Risk Assessment
Risk Level: medium — Quarterly reports can reveal significant financial shifts or operational challenges that impact stock value.
Key Numbers
- 2025-06-30 — Period End Date (The end of the reporting quarter)
- 2025-01-01 — Period Start Date (The start of the reporting quarter)
Key Players & Entities
- Teladoc Health, Inc. (company) — Filer of the 10-Q report
- 155 E 44th Street, Floor 17, New York, NY 10017 (location) — Principal executive offices address
- 20250630 (date) — Conformed period of report
- 20250730 (date) — Filed as of date
FAQ
What is the filing type and period covered?
The filing is a 10-Q report for the period ending June 30, 2025.
Where are Teladoc Health's principal executive offices located?
Teladoc Health's principal executive offices are located at 155 E 44th Street, Floor 17, New York, NY 10017.
What is the SEC file number for Teladoc Health?
The SEC file number for Teladoc Health is 001-37477.
When was the company formerly known as Teladoc, Inc.?
The company was formerly known as Teladoc, Inc. and the date of the name change was November 23, 2009.
What is the fiscal year end for Teladoc Health?
Teladoc Health's fiscal year ends on December 31.
From the Filing
0001477449-25-000099.txt : 20250730 0001477449-25-000099.hdr.sgml : 20250730 20250730125234 ACCESSION NUMBER: 0001477449-25-000099 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 88 CONFORMED PERIOD OF REPORT: 20250630 FILED AS OF DATE: 20250730 DATE AS OF CHANGE: 20250730 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Teladoc Health, Inc. CENTRAL INDEX KEY: 0001477449 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011] ORGANIZATION NAME: 08 Industrial Applications and Services EIN: 043705970 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-37477 FILM NUMBER: 251165630 BUSINESS ADDRESS: STREET 1: 155 E 44TH STREET STREET 2: FLOOR 17 CITY: NEW YORK STATE: NY ZIP: 10017 BUSINESS PHONE: 2036352002 MAIL ADDRESS: STREET 1: 155 E 44TH STREET STREET 2: FLOOR 17 CITY: NEW YORK STATE: NY ZIP: 10017 FORMER COMPANY: FORMER CONFORMED NAME: Teladoc, Inc. DATE OF NAME CHANGE: 20091123 10-Q 1 tdoc-20250630.htm 10-Q tdoc-20250630 0001477449 2025 --12-31 Q2 false 6 1 http://www.teladoc.com/20250630#AccruedLiabilitiesAndOtherLiabilitiesExcludingAccruedCompensationCurrent http://www.teladoc.com/20250630#AccruedLiabilitiesAndOtherLiabilitiesExcludingAccruedCompensationCurrent 0.0041258 P1Y P1Y P2Y 0.3333 0.3333 xbrli:shares iso4217:USD iso4217:USD xbrli:shares tdoc:professional_association tdoc:professional_corporation xbrli:pure tdoc:segment tdoc:debtInstrument tdoc:day 0001477449 2025-01-01 2025-06-30 0001477449 2025-07-23 0001477449 2025-06-30 0001477449 2024-12-31 0001477449 2025-04-01 2025-06-30 0001477449 2024-04-01 2024-06-30 0001477449 2024-01-01 2024-06-30 0001477449 us-gaap:CommonStockMember 2025-03-31 0001477449 us-gaap:AdditionalPaidInCapitalMember 2025-03-31 0001477449 us-gaap:RetainedEarningsMember 2025-03-31 0001477449 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-03-31 0001477449 2025-03-31 0001477449 us-gaap:CommonStockMember 2025-04-01 2025-06-30 0001477449 us-gaap:AdditionalPaidInCapitalMember 2025-04-01 2025-06-30 0001477449 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-04-01 2025-06-30 0001477449 us-gaap:RetainedEarningsMember 2025-04-01 2025-06-30 0001477449 us-gaap:CommonStockMember 2025-06-30 0001477449 us-gaap:AdditionalPaidInCapitalMember 2025-06-30 0001477449 us-gaap:RetainedEarningsMember 2025-06-30 0001477449 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-06-30 0001477449 us-gaap:CommonStockMember 2024-12-31 0001477449 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0001477449 us-gaap:RetainedEarningsMember 2024-12-31 0001477449 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-12-31 0001477449 us-gaap:CommonStockMember 2025-01-01 2025-06-30 0001477449 us-gaap:AdditionalPaidInCapitalMember 2025-01-01 2025-06-30 0001477449 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-01-01 2025-06-30 0001477449 us-gaap:RetainedEarningsMember 2025-01-01 2025-06-30 0001477449 us-gaap:CommonStockMember 2024-03-31 0001477449 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0001477449 us-gaap:RetainedEarningsMember 2024-03-31 0001477449 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-03-31 0001477449 2024-03-31 0001477449 us-gaap:CommonStockMember 2024-04-01 2024-06-30 0001477449 us-gaap:AdditionalPaidInCapitalMember 2024-04-01 2024-06-30 0001477449 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-04-01 2024-06-30 0001477449 us-gaap:RetainedEarningsMember 2024-04-01 2024-06-30 0001477449 us-gaap:CommonStockMember 2024-06-30 0001477449 us-gaap:AdditionalPaidInCapitalMember 2024-06-30 0001477449 us-gaap:RetainedEarningsMember 2024-06-30 0001477449 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-06-30 0001477449 2024-06-30 0001477449 us-gaap:CommonStockMember 2023-12-31 0001477449 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001477449 us-gaap:RetainedEarningsMember 2023-12-31 0001477449 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-31 0001477449 2023-1